Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO.
Daniele RossiniCarlotta AntoniottiSara LonardiFilippo PietrantonioRoberto MorettoLorenzo AntonuzzoAlessandra BoccaccinoFederica MoranoMarco BrugiaCarmelo PozzoFederica MarmorinoFrancesca BergamoEmiliano TamburiniAlessandro PassardiGiovanni RandonSabina MurgioniBeatrice BorelliAngela BuonadonnaMirella GiordanoGabriella FontaniniVeronica ConcaVincenzo FormicaMassimo AgliettaRoberto BordonaroGiuseppe AprileGianluca MasiLuca BoniChiara CremoliniPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
wt mCRC.